Dendritic cell-based cancer immunotherapy in the era of immune checkpoint inhibitors: From bench to bedside.
Ghorbaninezhad F, Asadzadeh Z, Masoumi J, Mokhtarzadeh A, Kazemi T, Aghebati-Maleki L, Shotorbani SS, Shadbad MA, Baghbanzadeh A, Hemmat N, Bakhshivand M, Baradaran B.
Ghorbaninezhad F, et al. Among authors: asadzadeh z.
Life Sci. 2022 May 15;297:120466. doi: 10.1016/j.lfs.2022.120466. Epub 2022 Mar 7.
Life Sci. 2022.
PMID: 35271882
Review.